1 year return (CAGR)
12.89%
Gefran S.p.A Exchange (MI, EUR)
GE.MI
-
-0.05 (-0.49%)
TechnologyElectronic Components
Loading...
3 year return (CAGR)
1.51%
5 year return (CAGR)
11.12%
10 year return (CAGR)
20.68%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
145.57M
Price/Sales
1.07
Ent value
154.74M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
14.82
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 10.30 |
| Daily high | 10.55 |
| Daily low | 10.25 |
| Daily Volume | 5K |
| 1y analyst estimate | 13.20 |
| Beta | 1.07 |
| EPS (TTM) | 0.69 |
| Dividend per share | 0.00 |
| Ex-div date | 5 May 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GE.MI | S&P500 | |
| Current price drop from All-time high | -99.91% | -0.89% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 12 Feb 2016 | 9 Mar 2009 |
| Avg drop from high | -98.48% | -10.64% |
| Avg time to new high | 3505 days | 12 days |
| Max time to new high | 7009 days | 1805 days |
News
LLY, NVS and BAYRY stand out as the pharma sector rebounds in 2026, supported by innovative drug pipelines, strong product demand and rising earnings estimates.
November 10, 2026
The European stock markets closed higher in Monday trading amid easing bond yields and oil prices, f
November 9, 2026
Press release - Regulated Information Melexis: update on the share buy-back program Ieper, Belgium – 9 November 2026, 17.45 hrs CET Melexis reports the purchase of 28,100 Melexis shares on Euronext Br...
November 9, 2026
In the Large-Cap Pharmaceuticals industry, LLY, NVS and BAYRY are worth watching as the industry shows a strong recovery.
November 9, 2026
Novartis (NVS) will discontinue development of its experimental drug, pelacarsen, for atheroscleroti
November 9, 2026
Alerion Clean Power has seen its share price move around in recent years, and that leaves investors asking a simple question. Does the current €18.38 price tag line up with what the business is earnin...
November 8, 2026
Spadel has delivered a strong share price run over the past few years, and that kind of move naturally raises a question for you as an investor. Is the current price around €340 really in line with wh...
November 8, 2026
Why the new Astroscale agreement matters for OHB OHB (XTRA:OHB) just signed a Memorandum of Understanding with Astroscale Holdings that targets joint work in space security, space domain awareness, an...
November 8, 2026
Norwegian Air Shuttle (OB:NAS) is back in focus after Barclays upgraded the stock, citing lower spot and forward fuel prices along with a stronger sector outlook for airlines. Recent trading reflects ...
November 8, 2026
Electrification is moving from climate slogan to policy to-do list, and potential COP31 commitments on cleaner power and transport could put EV charging networks on the front line. That shift matters ...
November 8, 2026